| Date | Title | Presentation | Webcast |
| December 21, 2011 | Teva to Host 2012 Business Outlook Conference Call |
|  |
| December 6, 2011 | Teva Pharmaceutical Industries Ltd at NASDAQ OMX Group Inc Investor Program |  | |
| November 30, 2011 | Teva Pharmaceutical Industries Ltd at Piper Jaffray Health Care Conference |
| |
| November 10, 2011 | Teva Presentation at the Credit Suisse Healthcare Conference | | |
| November 2, 2011 | 3rd Quarter 2011 Earnings Conference Call |
| |
| September 20, 2011 | Teva Presentation at the UBS Global Life Sciences Conference | | |
| September 14, 2011 | Teva Presentation at the Morgan Stanley Global Healthcare Conference |
| |
| September 14, 2011 | Teva Presentation at the Bank of America Merrill Lynch Global Healthcare Conference | | |
| August 1, 2011 | Teva Pharmaceutical Industries Ltd Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment - Conference call |
| |
| July 27, 2011 | 2nd Quarter 2011 Earnings Conference Call |
| |
| June 7, 2011 | Teva Pharmaceutical Industries Ltd at Goldman Sachs Global Healthcare Conference |
| |
| May 16, 2011 | Investor Call to Discuss the Acquisition of Taiyo | | |
| May 11, 2011 | 1st Quarter 2011 Earnings Conference Call |
| |
| May 4, 2011 | Teva Presentation at the Deutsche Bank 36th Annual Health Care Conference |
| |
| May 2, 2011 | Investor Call to Discuss the Acquisition of Cephalon | | |
| March 24, 2011 | Presentation from Joint call with P&G to discuss Consumer Health Care Partnership | | |
| March 16, 2011 | Presentation at the Barclays Capital 2011 Global Healthcare Conference | | |
| February 9, 2011 | Teva Investor and Analyst Meeting | | |
| February 8, 2011 | 4th Quarter and Full Year 2010 Earnings Conference Call |
| |
| January 11, 2011 | Presentation at the 29th Annual J.P. Morgan Healthcare Conference | | |
| January 6, 2011 | Presentation at the Goldman Sachs Healthcare CEOs Unscripted Conference | | |
